Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 66 of 66 entries
View as:
Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 08/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/18/22
End: 09/08/25
Due: 09/08/26
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 02/28/18
Due: 02/28/19
Phase: N/A
Priority: Normal
Start: 03/08/23
End: 05/25/24
Due: 05/25/25
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 10/17/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 08/23/23
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 12/06/24
End: 12/30/28
Due: 12/30/29
Phase: N/A
Priority: Normal
Start: 04/02/20
End: 09/30/21
Due: 09/30/22